RE: Sub 9p coming!5 Oct 2023 13:41
More utter delusion here. All the holders blaming Budd. Do you think any CEO would have somehow done any better then??? Really? The answer is a resounding 'No'. Unless you think someone out there can circumvent the NHS apparatus, Buying committees, procurement processes, layers of decision makers and all the structures in place? This is the reality of selling something Novel into the NHS sadly. It takes years. I said back in 2021 this would be a 3-5 year journey and that the short term funding doesn't fit with the long term needs of the business. Now here we are. The mistake Budd made wasn't sales, it was not selling the business when approached. He thought he'd hold out for a better personal deal despite no cashflow, under the belief he'd get a higher multiple for GDR. Well that was silly as it generates little if any cash, so he should have taken the deal at circa 30p per share. The new CEO will sell up and is why he is there.